Rights and permissions
About this article
Cite this article
Indobufen vs heparins for prophylaxis of postop complications. Pharmacoecon. Outcomes News 71, 5 (1996). https://doi.org/10.1007/BF03270147
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270147